Affinity Capital Advisors
BSX icon

Affinity Capital Advisors’s Boston Scientific BSX Stock Holding History

Affinity Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$450K Sell
10,523
-397
-4% -$18.4K 0.05% 124
2026
Q2 		$487K Buy
10,920
+1,054
+11% +$57.2K 0.06% 115
2026
Q1 		$619K Buy
+9,866
New +$789K 0.09% 88

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Affinity Capital Advisors's BSX Position: Q3 2026 in Review

Affinity Capital Advisors reduced its Boston Scientific (BSX) stake by 3.6% in Q3 2026, selling an estimated $18.4K and leaving 10,523 shares worth $450K. The position accounts for 0.05% of the portfolio, ranked #124.

Affinity Capital Advisors first reported a position in BSX in Q1 2026 and has held it in 3 quarters since. The position peaked at $619K in Q1 2026. 406 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Affinity Capital Advisors held 10,523 shares of Boston Scientific worth $450K as of Q3 2026.
  • Affinity Capital Advisors sold 397 Boston Scientific shares in Q3 2026, an estimated $18.4K.
  • Boston Scientific made up 0.05% of Affinity Capital Advisors's portfolio in Q3 2026, its #124 holding.
  • Affinity Capital Advisors first reported a position in Boston Scientific in Q1 2026 and has held it in 3 quarters since.
  • Affinity Capital Advisors's Boston Scientific position peaked at $619K in Q1 2026.
  • 406 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Affinity Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.